BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25595474)

  • 1. Triazine-modified dendrimer for efficient TRAIL gene therapy in osteosarcoma.
    Wang Y; Li L; Shao N; Hu Z; Chen H; Xu L; Wang C; Cheng Y; Xiao J
    Acta Biomater; 2015 Apr; 17():115-24. PubMed ID: 25595474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival.
    Picarda G; Lamoureux F; Geffroy L; Delepine P; Montier T; Laud K; Tirode F; Delattre O; Heymann D; Rédini F
    Clin Cancer Res; 2010 Apr; 16(8):2363-74. PubMed ID: 20371692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements.
    Xiao F; Chen J; Lian C; Han P; Zhang C
    Mol Med Rep; 2015 Jan; 11(1):739-45. PubMed ID: 25335093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor-related apoptosis inducing ligand in osteosarcoma pre-clinical models.
    Guiho R; Biteau K; Grisendi G; Chatelais M; Brion R; Taurelle J; Renault S; Heymann D; Dominici M; Redini F
    Cytotherapy; 2018 Aug; 20(8):1037-1045. PubMed ID: 30093324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcoma.
    Lamoureux F; Picarda G; Garrigue-Antar L; Baud'huin M; Trichet V; Vidal A; Miot-Noirault E; Pitard B; Heymann D; Rédini F
    Cancer Res; 2009 Jan; 69(2):526-36. PubMed ID: 19147566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent growth-inhibitory effect of TRAIL therapy mediated by double-regulated oncolytic adenovirus on osteosarcoma.
    Li C; Cheng Q; Liu J; Wang B; Chen D; Liu Y
    Mol Cell Biochem; 2012 May; 364(1-2):337-44. PubMed ID: 22354724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ether à go-go 1 silencing in combination with TRAIL overexpression has synergistic antitumor effects on osteosarcoma.
    Wu J; Zeng T; Wu X; Gao Q; Zhai W; Ding Z
    Cancer Biother Radiopharm; 2013 Feb; 28(1):65-70. PubMed ID: 23145797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome.
    Nakase M; Inui M; Okumura K; Kamei T; Nakamura S; Tagawa T
    Mol Cancer Ther; 2005 Apr; 4(4):625-31. PubMed ID: 15827336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified PAMAM vehicles for effective TRAIL gene delivery to colon adenocarcinoma: in vitro and in vivo evaluation.
    Pishavar E; Attaranzadeh A; Alibolandi M; Ramezani M; Hashemi M
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S503-S513. PubMed ID: 30095012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of doxorubicin and TRAIL plasmid by modified PAMAM dendrimer in colon cancer cells,
    Pishavar E; Ramezani M; Hashemi M
    Drug Dev Ind Pharm; 2019 Dec; 45(12):1931-1939. PubMed ID: 31609130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of VEGF-siRNA mediated by adenovirus on osteosarcoma-bearing nude mice.
    Gao YS; Mei J; Tong TL; Hu M; Xue HM; Cai XS
    Cancer Biother Radiopharm; 2009 Apr; 24(2):243-7. PubMed ID: 19409047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of targeting gene-viro therapy with recombinant Fowl-pox viruses with HN and VP3 genes on mouse osteosarcoma.
    Zhang ZY; Wang LQ; Fu CF; Li X; Cui ZL; Zhang JY; Xue SH; Sun N; Xu F
    Eur Rev Med Pharmacol Sci; 2013 Mar; 17(6):767-76. PubMed ID: 23609360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas.
    Grisendi G; Spano C; D'souza N; Rasini V; Veronesi E; Prapa M; Petrachi T; Piccinno S; Rossignoli F; Burns JS; Fiorcari S; Granchi D; Baldini N; Horwitz EM; Guarneri V; Conte P; Paolucci P; Dominici M
    Stem Cells; 2015 Mar; 33(3):859-69. PubMed ID: 25420617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene.
    Kagawa S; He C; Gu J; Koch P; Rha SJ; Roth JA; Curley SA; Stephens LC; Fang B
    Cancer Res; 2001 Apr; 61(8):3330-8. PubMed ID: 11309289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization of multidrug resistant human ostesarcoma cells to Apo2 Ligand/TRAIL-induced apoptosis by inhibition of the Akt/PKB kinase.
    Cenni V; Maraldi NM; Ruggeri A; Secchiero P; Del Coco R; De Pol A; Cocco L; Marmiroli S
    Int J Oncol; 2004 Dec; 25(6):1599-608. PubMed ID: 15547696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-tumor effect of eukaryotic expressing plasmid containing soluble tumor necrotic factor-related apoptosis inducing ligand combined with human angiostatin Kringle (1 - 3) genes on human gastric cancer xenografts in nude mice].
    Sun W; Jiang Z; Xiang TX; Tao XH; Huang AL; Wang PL
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):841-5. PubMed ID: 19595126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrovirus-mediated transduction of TRAIL and chemotherapeutic agents co-operatively induce apoptotic cell death in both sarcoma and myeloma cells.
    Suzuki H; Hotta T; Koyama T; Komagata M; Imakiire A; Yanase N; Yoshimoto T; Mizuguchi J
    Anticancer Res; 2003; 23(4):3247-53. PubMed ID: 12926060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer agents sensitize osteosarcoma cells to TNF-related apoptosis-inducing ligand downmodulating IAP family proteins.
    Mirandola P; Sponzilli I; Gobbi G; Marmiroli S; Rinaldi L; Binazzi R; Piccari GG; Ramazzotti G; Gaboardi GC; Cocco L; Vitale M
    Int J Oncol; 2006 Jan; 28(1):127-33. PubMed ID: 16327988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antitumor effect of endothelial progenitor cells with TRAIL gene transfection on ovarian carcinoma xenografts in nude mice].
    Zhou L; Yan MX; Yao M; Feng YJ
    Ai Zheng; 2005 Nov; 24(11):1312-6. PubMed ID: 16552954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRAIL-secreting human mesenchymal stem cells engineered by a non-viral vector and photochemical internalization for pancreatic cancer gene therapy.
    Han J; Hwang HS; Na K
    Biomaterials; 2018 Nov; 182():259-268. PubMed ID: 30142525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.